Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
AstraZeneca
Colorcon
Moodys
Harvard Business School

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

Fougera Pharms Inc Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for FOUGERA PHARMS INC, and when can generic versions of FOUGERA PHARMS INC drugs launch?

FOUGERA PHARMS INC has thirty approved drugs.

There are three US patents protecting FOUGERA PHARMS INC drugs.

There are forty-two patent family members on FOUGERA PHARMS INC drugs in twenty countries and thirty supplementary protection certificates in fifteen countries.

Summary for Fougera Pharms Inc
International Patents:42
US Patents:3
Tradenames:17
Ingredients:17
NDAs:30

Drugs and US Patents for Fougera Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms Inc FLUOCINOLONE ACETONIDE fluocinolone acetonide CREAM;TOPICAL 088170-001 Dec 16, 1982 AT RX No No   Start Trial   Start Trial
Fougera Pharms Inc CLOBETASOL PROPIONATE clobetasol propionate CREAM;TOPICAL 074392-001 Sep 30, 1996 AB1 RX No No   Start Trial   Start Trial
Fougera Pharms Inc TACROLIMUS tacrolimus OINTMENT;TOPICAL 200744-002 Sep 9, 2014 AB RX No No   Start Trial   Start Trial
Fougera Pharms Inc BETAMETHASONE DIPROPIONATE betamethasone dipropionate OINTMENT;TOPICAL 019141-001 Sep 4, 1984 AB RX Yes Yes   Start Trial   Start Trial
Fougera Pharms Inc NITROGLYCERIN nitroglycerin OINTMENT;TRANSDERMAL 087355-001 Jul 8, 1988 RX No Yes   Start Trial   Start Trial
Fougera Pharms Inc FLUOCINONIDE fluocinonide CREAM;TOPICAL 200735-001 Jul 14, 2014 AB RX No No   Start Trial   Start Trial
Fougera Pharms Inc FLUOCINOLONE ACETONIDE fluocinolone acetonide OINTMENT;TOPICAL 088168-001 Dec 16, 1982 AT RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for Fougera Pharms Inc Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0284288 12/1998 Austria   Start Trial PRODUCT NAME: TAZAROTENE; NAT. REGISTRATION NO/DATE: 1-22102, 1-22103 19970918; FIRST REGISTRATION: DE 37393.00.00, 37393.01.00 19961203
0284288 SPC/GB98/002 United Kingdom   Start Trial PRODUCT NAME: TAZAROTENE : ETHYL 6-(2-(4,4-DIMETHYLTHIOCHROMAN-6-YL) ETHYNYL) NICOTINOATE; REGISTERED: DE 37393.00.00 19961203; DE 37393.01.00 19961203; UK 00426/0097 19970730; UK 00426/0096 19970730
1304992 122013000081 Germany   Start Trial PRODUCT NAME: CLINDAMYCIN (ALS CLINDAMYCIN-PHOSPHAT) UND TRETINOIN; NAT. REGISTRATION NO/DATE: 85210.00.00 20130611; FIRST REGISTRATION: IRLAND PA1332/043/001 20130322
1304992 2013/044 Ireland   Start Trial PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322
2055300 C201600002 Spain   Start Trial PRODUCT NAME: EXTRACTO SECO DE CAMELIA SINENSIS (L) O. KUNTZE FOLIUM (HOJA DE TE VERDE) CORRESPONDIENTE A GALATO DE (-)-EPIGALOCATEQUINA (EGCG).; NATIONAL AUTHORISATION NUMBER: 71435; DATE OF AUTHORISATION: 20110208; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): 73486.00.00; DATE OF FIRST AUTHORISATION IN EEA: 20090831
0809498 10C0038 France   Start Trial PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
0842660 C00842660/01 Switzerland   Start Trial PRODUCT NAME: CAMELLIAE SINENSIS EXTRACTUM SICCUM RAFFINATUM; REGISTRATION NUMBER/DATE: SWISSMEDIC 61895 27.03.2012
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Colorcon
Express Scripts
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.